ASA: Pre-Hospital tPA May Reduce Stroke Disability

Share this content:
ASA: Pre-Hospital tPA May Reduce Stroke Disability
ASA: Pre-Hospital tPA May Reduce Stroke Disability

FRIDAY, Feb. 24, 2017 (HealthDay News) -- Patients transported in an ambulance specially equipped to diagnose and treat stroke on route to the hospital have a lower risk of stroke-related disability than patients who receive tissue plasminogen activator (tPA) at the hospital, according to research presented at the annual American Stroke Association's International Stroke Conference, held from Feb. 22 to 24 in Houston.

May Nour, M.D., Ph.D., of the University of California's Mobile Stroke Rescue Program in Los Angeles, and colleagues compared 305 patients given tPA in a mobile stroke unit with 353 patients who got tPA at the hospital. The team used data from Berlin's PHANTOM-S study.

The researchers concluded that for every 1,000 stroke patients given tPA on their way to the hospital, 182 will be less disabled by their stroke and 58 will have no disability at all, compared to those treated in hospital only. The team noted that the findings bordered on statistical significance, and additional research is needed.

Treatment "needs to happen as quickly as possible, and a mobile stroke unit may allow that to happen," Nour said in a news release from the American Stroke Association.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »